Skip to menu Skip to content Skip to footer

2007

Conference Publication

Intravenous versus oral iron supplementation in peritoneal dialysis patients

Johnson, David W. (2007). Intravenous versus oral iron supplementation in peritoneal dialysis patients. The 11th Congress of the International Society for Peritoneal Dialysis, Hong Kong, 25-29 August, 2006. Milton, Ontario: Multimed Inc..

Intravenous versus oral iron supplementation in peritoneal dialysis patients

2007

Journal Article

Update for GPs on the management of mild to moderate renal impairment.

Mathew, T. and Johnson, D. (2007). Update for GPs on the management of mild to moderate renal impairment.. Medical Observer, 31-34.

Update for GPs on the management of mild to moderate renal impairment.

2007

Conference Publication

MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failure

Liu, H., McTaggart, S., Li, J., Johnson, D. W. and Gobe, G. C. (2007). MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failure. World Congress of Nephrology 2007, Rio de Janeiro, Brazil, 21-25 April 2007. International Society of Nephrology.

MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failure

2007

Conference Publication

Access infection in dialysis patients: A comparison of peritoneal vs haemodialysis in a large dialysis population

Clark, C. J., Johnson, D., Hawley, C., May, K., Campbell, S., Isbel, N., Mudge, D. and Burke, J. (2007). Access infection in dialysis patients: A comparison of peritoneal vs haemodialysis in a large dialysis population. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell Publishing.

Access infection in dialysis patients: A comparison of peritoneal vs haemodialysis in a large dialysis population

2007

Conference Publication

Erythropoietin: Novel applications beyond anaemia treatment

Vesey, D. A., Gobe, G. C. and Johnson, D. W. (2007). Erythropoietin: Novel applications beyond anaemia treatment. 2nd International Conference of Naresuan University, Phitsanulok, Thailand, 27-28 July, 2007.

Erythropoietin: Novel applications beyond anaemia treatment

2007

Journal Article

Modification of cardiovascular risk in hemodialysis patients: an evidence-based review

Johnson, David W., Craven, Ann-Maree and Isbel, Nicole Maree (2007). Modification of cardiovascular risk in hemodialysis patients: an evidence-based review. Hemodialysis International, 11 (1), 1-14. doi: 10.1111/j.1542-4758.2007.00146.x

Modification of cardiovascular risk in hemodialysis patients: an evidence-based review

2007

Conference Publication

Vascular and structural cell response to erythropoietin in the neonatal brain during hypoxic injury

Yamada, M., Burke, C., Colditz, P., Johnson, D. W. and Gobe, G. C. (2007). Vascular and structural cell response to erythropoietin in the neonatal brain during hypoxic injury. Australian Society of Medical Research Annual Scientific Meeting, Blue Mountains, NSW, November, 2007.

Vascular and structural cell response to erythropoietin in the neonatal brain during hypoxic injury

2007

Conference Publication

Follow-up of 15 years of live donors in a large Australian renal transplant unit

Kaisar, M. O., Isbel, N., Hawley, C., Johnson, D., Mudge, D., Griffin, A., Wall, D., Preston, J., Nicol, D. and Campbell, S. (2007). Follow-up of 15 years of live donors in a large Australian renal transplant unit. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

Follow-up of 15 years of live donors in a large Australian renal transplant unit

2007

Conference Publication

TRAFs, CARDs and CIDEs are novel apoptotic gene families in therapy-treated renal cell carcinoma and potential diagnostic markers

Rajandram, R., Pat, B. K., Li, J., Percy, C. J., Johnson, D. W. and Gobe, G. C. (2007). TRAFs, CARDs and CIDEs are novel apoptotic gene families in therapy-treated renal cell carcinoma and potential diagnostic markers. National Cancer Research Institute Conference, Birmingham, England, 2-5 October, 2007.

TRAFs, CARDs and CIDEs are novel apoptotic gene families in therapy-treated renal cell carcinoma and potential diagnostic markers

2007

Conference Publication

The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy

Li, J., Vesey, D. A., Johnson, D. W. and Gobe, G. C. (2007). The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy. 32nd Lorne Conference on Protein Structure and Function, Lorne, Victoria, Australia, 4-8 February 2007. Lorne, Vic., Australia:

The effect of recombinant human erythropoietin (rhEPO) in renal cell carcinoma (RCC) chemotherapy

2007

Conference Publication

Hospital admission rates in alternate nightly nocturnal home haemodialysis

Van Eps, C. L., Jeffries, J. K., Ng, T. G., Isbel, N. M., Johnson, D. W., Campbell, S. B., Mudge, D. W. and Hawley, C. M. (2007). Hospital admission rates in alternate nightly nocturnal home haemodialysis. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

Hospital admission rates in alternate nightly nocturnal home haemodialysis

2007

Conference Publication

Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients

Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Ghandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients. American Transplant Congress 2007, USA, 5-9 May 2007. UK: Wiley-Blackwell Publising Ltd.. doi: 10.1111/j.1600-6143.2007.01811.x

Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients

2007

Journal Article

Administration of erythropoietin and its derivatives in renal disease: advantages, mechanisms and concerns

Gobe, Glenda C., Endre, Zoltan H. and Johnson, David W. (2007). Administration of erythropoietin and its derivatives in renal disease: advantages, mechanisms and concerns. Drug Discovery Today: Therapeutic Strategies, 4 (1), 79-84. doi: 10.1016/j.ddstr.2007.07.001

Administration of erythropoietin and its derivatives in renal disease: advantages, mechanisms and concerns

2007

Book Chapter

Hypokalaemia and Metabolic Alkalosis

Johnson, David W. (2007). Hypokalaemia and Metabolic Alkalosis. Clinical Cases in Kidney Disease. (pp. 1-1) edited by D.C.H. Harris. North Ryde, NSW Australia: McGraw-Hill Australia.

Hypokalaemia and Metabolic Alkalosis

2007

Conference Publication

MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failure

Liu, H., McTaggart S., Johnson, D. W. and Gobe, G. C. (2007). MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failure. World Congress of Nephrology 2007 (WCN2007), Rio de Janeiro, Brazil, 21-25 April 2007. International Society of Nephrology.

MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failure

2007

Conference Publication

The effect of diabetes mellitus on access related infection in both peritoneal dialysis and haemodialysis patients

Clark, C. J., Johnson, D., Hawley, C., May, K., Campbell, S., Isbel, N., Mudge, D. and Burke, J. (2007). The effect of diabetes mellitus on access related infection in both peritoneal dialysis and haemodialysis patients. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

The effect of diabetes mellitus on access related infection in both peritoneal dialysis and haemodialysis patients

2007

Conference Publication

Mycophenolic acid AUC on day 5 post-renal transplant and related outcomes in the early post-operative period

Staatz, Christine, Wong, Jenny, Taylor, Paul, Johnson, David and Tett, Susan (2007). Mycophenolic acid AUC on day 5 post-renal transplant and related outcomes in the early post-operative period. 10th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology, Nice, France, 9-14 September, 2007. New York: Lippincott-Raven. doi: 10.1097/FTD.0b013e31813797e8

Mycophenolic acid AUC on day 5 post-renal transplant and related outcomes in the early post-operative period

2007

Journal Article

Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with periotoneal dialysis

Craven, Ann-Maree S., Hawley, Carmel M., McDonald, Stephen P., Rosman, Johan B., Brown, Fiona G. and Johnson, David W. (2007). Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with periotoneal dialysis. Peritoneal Dialysis International, 27 (2), 184-191. doi: 10.1177/089686080702700216

Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with periotoneal dialysis

2007

Journal Article

Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigs

Forman, Colin J., Johnson, David W. and Nicol, David L. (2007). Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigs. BJU International, 99 (1), 162-165. doi: 10.1111/j.1464-410X.2006.06505.x

Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigs

2007

Conference Publication

The prevalence of obesity in CKD

Frazier, J., Johnson, D., Hawley, C., Campbell, S., Mudge, D., Van Eps, C., Isbel, N. and Leslie, J. (2007). The prevalence of obesity in CKD. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

The prevalence of obesity in CKD